Company / Inventory
Apellis Pharmaceuticals, Inc. Inventory History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$142.6M
FY2025
5-year range
$16.3M / $146.4M
FY2021-FY2025
Trend
+75.1%
vs FY2024
Sector context
#38 of 105
Health Care
What the data says
At $143M, Apellis Pharmaceuticals, Inc.'s inventory ranks #38 of 105 in the Health Care sector. Declined from $146M to $143M over the past 2 years.
Based on SEC 10-K filings.
$143M in FY2025 with a 3-year CAGR of +18.5%.
Declined from $146M to $143M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#38 of 105 in Health CareTop 36% of 105This company $142.6M Sector average $885.3M
▼
-83.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +18.5%, indicating consistent growth.
- In FY2025, inventory increased 75.1% year-over-year.
- Ranks #38 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $142.6M | +75.1% |
| FY2024 | $81.4M | -44.4% |
| FY2023 | $146.4M | +70.8% |
| FY2022 | $85.7M | +426.3% |
| FY2021 | $16.3M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026